REMPR
TEVA icon

Roof Eidam Maycock Peralta (REMP)’s Teva Pharmaceuticals TEVA Stock Holding History

Roof Eidam Maycock Peralta (REMP)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,335
Closed -$955K – 93
2015
Q1 		$955K Sell
15,335
-485
-3% -$28.2K 0.77% 36
2014
Q4 		$910K Buy
+15,820
New +$881K 0.77% 39

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Roof Eidam Maycock Peralta (REMP)'s TEVA Position: Q2 2015 in Review

Roof Eidam Maycock Peralta (REMP) sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 15,335 shares — an estimated $955K sold.

Roof Eidam Maycock Peralta (REMP) first reported a position in TEVA in Q4 2014 and held it in 2 quarters. The position peaked at $955K in Q1 2015. 819 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

  • Roof Eidam Maycock Peralta (REMP) reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Roof Eidam Maycock Peralta (REMP) sold 15,335 Teva Pharmaceuticals shares in Q2 2015, an estimated $955K.
  • Roof Eidam Maycock Peralta (REMP) first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Roof Eidam Maycock Peralta (REMP)'s Teva Pharmaceuticals position peaked at $955K in Q1 2015.
  • 819 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Roof Eidam Maycock Peralta (REMP)'s 13F filing for Q2 2015, filed 7 Aug 2015.